Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miki Ando

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 5, 2022
[Induced pluripotent stem cell-derived rejuvenated cytotoxic T lymphocyte therapy for Epstein-Barr virus-associated lymphomas: application to clinical practice]Miki Ando
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 6, 2025
[iPSC-derived next-generation T cell therapy for refractory malignancies]Miki Ando
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 3, 2025
[What is needed now to develop female leaders]Miki Ando
Experimental Hematology|November 10, 2016
'Off-the-shelf' immunotherapy with iPSC-derived rejuvenated cytotoxic T lymphocytesMiki Ando, Hiromitsu Nakauchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 7, 2018
[iPSC-derived rejuvenated T-cell therapy for Epstein-Barr virus-associated lymphomas]Miki Ando, Hiromitsu Nakauchi, Norio Komatsu
Clinical Lymphoma, Myeloma & Leukemia|December 27, 2025
Persistent COVID-19 in Patients With Hematological Malignancies: A Focused Review in the Omicron EraHajime Yasuda, Jun Ando, Miki Ando
European Journal of Haematology|June 20, 2002
Mononucleosis syndrome and acute monocytic leukemiaKenji Tamayose, Koichi Sugimoto, Miki Ando, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 10, 2022
Hodgkin Lymphoma on Hemodialysis: A Review of Treatment and RecommendationsHajime Yasuda, Norio Komatsu, Jun Ando, et al.
Annals of Hematology|August 24, 2022
Bosutinib-induced late-onset severe liver injury preceded by eosinophiliaNaoki Watanabe, Tomoiku Takaku, Isao Fujioka, et al.
Biochemical and Biophysical Research Communications|November 27, 2007
Changes in cell morphology and cytoskeletal organization are induced by human mitotic checkpoint gene, Bub1Jun Ando, Koichi Sugimoto, Kenji Tamayose, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 5, 2022
[Induced pluripotent stem cell-derived rejuvenated cytotoxic T lymphocyte therapy for Epstein-Barr virus-associated lymphomas: application to clinical practice]Miki Ando
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 6, 2025
[iPSC-derived next-generation T cell therapy for refractory malignancies]Miki Ando
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 3, 2025
[What is needed now to develop female leaders]Miki Ando
Experimental Hematology|November 10, 2016
'Off-the-shelf' immunotherapy with iPSC-derived rejuvenated cytotoxic T lymphocytesMiki Ando, Hiromitsu Nakauchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 7, 2018
[iPSC-derived rejuvenated T-cell therapy for Epstein-Barr virus-associated lymphomas]Miki Ando, Hiromitsu Nakauchi, Norio Komatsu
Clinical Lymphoma, Myeloma & Leukemia|December 27, 2025
Persistent COVID-19 in Patients With Hematological Malignancies: A Focused Review in the Omicron EraHajime Yasuda, Jun Ando, Miki Ando
European Journal of Haematology|June 20, 2002
Mononucleosis syndrome and acute monocytic leukemiaKenji Tamayose, Koichi Sugimoto, Miki Ando, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 10, 2022
Hodgkin Lymphoma on Hemodialysis: A Review of Treatment and RecommendationsHajime Yasuda, Norio Komatsu, Jun Ando, et al.
Annals of Hematology|August 24, 2022
Bosutinib-induced late-onset severe liver injury preceded by eosinophiliaNaoki Watanabe, Tomoiku Takaku, Isao Fujioka, et al.
Biochemical and Biophysical Research Communications|November 27, 2007
Changes in cell morphology and cytoskeletal organization are induced by human mitotic checkpoint gene, Bub1Jun Ando, Koichi Sugimoto, Kenji Tamayose, et al.
Pageof 9